4 results on '"Mercandino A"'
Search Results
2. Metabolic syndrome and breast cancer prognosis
- Author
-
Harriet Johansson, Giuliana Gargano, Patrizia Pasanisi, Maggiorino Barbero, Angelica Mercandino, Salvatore Panico, Franco Berrino, Maria Chiara Bassi, Maria Piera Mano, Eleonora Bruno, Elisabetta Venturelli, Adele Traina, Elena Consolaro, Anna Villarini, Milena Simeoni, Maurizio Zarcone, Rocco Galasso, Bernardo Bonanni, Berrino, F, Villarini, A, Traina, A, Bonanni, B, Panico, Salvatore, Mano, Mp, Mercandino, A, Galasso, R, Barbero, M, Simeoni, M, Bassi, Mc, Consolaro, E, Johansson, H, Zarcone, M, Bruno, E, Gargano, G, Venturelli, E, and Pasanisi, P.
- Subjects
Adult ,Oncology ,Cancer Research ,medicine.medical_specialty ,Breast Neoplasms ,Body Mass Index ,Metastasis ,Breast cancer ,Risk Factors ,Internal medicine ,medicine ,Humans ,Breast cancer prognosis ,Survival rate ,Abdominal obesity ,Aged ,Neoplasm Staging ,Physical activity ,business.industry ,Middle Aged ,Prognosis ,medicine.disease ,Metabolic syndrome ,Obesity ,Confidence interval ,Diet ,Surgery ,Survival Rate ,Logistic Models ,Female ,Neoplasm Grading ,medicine.symptom ,business ,Body mass index ,Follow-Up Studies - Abstract
Metabolic syndrome (MS), conventionally defined by the presence of at least three out of five dysmetabolic traits (abdominal obesity, hypertension, low plasma HDL-cholesterol, high plasma glucose and high triglycerides), has been associated with an increased risk of several age-related chronic diseases, including breast cancer (BC). This may have prognostic implications for BC survivors. 2,092 early stage BC survivors aged 35-70, recruited in eleven Italian centres 0-5 years after surgical treatment (1.74 years on average), were followed-up over 2.8 years on average for additional BC-related events, including BC-specific mortality, distant metastasis, local recurrences and contralateral BC. At recruitment, 20 % of the patients had MS. Logistic regression models were carried out to generate OR and 95 % confidence intervals (CI) for new BC events associated with MS, adjusting for baseline pathological prognostic factors. New BC events occurred in 164 patients, including 89 distant metastases. The adjusted ORs for women with MS versus women without any MS traits were 2.17 (CI 1.31-3.60) overall, and 2.45 (CI 1.24-4.82) for distant metastasis. The OR of new BC events for women with only one or two MS traits was 1.40 (CI 0.91-2.16). All MS traits were positively associated with new BC events, and significantly so for low HDL and high triglycerides. MS is an important prognostic factor in BC. As MS is reversible through lifestyle changes, interventions to decrease MS traits in BC patients should be implemented in BC clinics.
- Published
- 2014
3. Adherence to WCRF/AICR cancer prevention recommendations and metabolic syndrome in breast cancer patients
- Author
-
Eleonora, Bruno, Giuliana, Gargano, Anna, Villarini, Adele, Traina, Harriet, Johansson, Maria Piera, Mano, Maria, Santucci De Magistris, Milena, Simeoni, Elena, Consolaro, Angelica, Mercandino, Maggiorino, Barbero, Rocco, Galasso, Maria Chiara, Bassi, Maurizio, Zarcone, Emanuela, Zagallo, Elisabetta, Venturelli, Manuela, Bellegotti, Franco, Berrino, and Patrizia, Pasanisi
- Subjects
Adult ,Metabolic Syndrome ,Cancer Research ,Advance Directive Adherence ,adherence to WCRF/AICR recommendation ,breast cancer prognosis ,metabolic syndrome prevalence ,Aged ,Breast Neoplasms ,Diet ,Feeding Behavior ,Female ,Humans ,Life Style ,Middle Aged ,Motor Activity ,Neoplasm Staging ,Prevalence ,Risk Factors ,Oncology - Abstract
Metabolic syndrome (MetS), conventionally defined by the presence of at least three out of five dismetabolic traits (abdominal obesity, hypertension, low plasma HDL-cholesterol and high plasma glucose and triglycerides), has been associated with both breast cancer (BC) incidence and prognosis. We investigated the association between the prevalence of MetS and a score of adherence to the World Cancer Research Fund (WCRF) and American Institute for Cancer Research (AICR) recommendations for the prevention of cancer in a cross-sectional study of BC patients. The DIet and ANdrogen-5 study (DIANA-5) for the prevention of BC recurrences recruited 2092 early stage BC survivors aged 35-70. At recruitment, all women completed a 24-hour food frequency and physical activity diary on their consumption and activity of the previous day. Using these diaries we created a score of adherence to five relevant WCRF/AICR recommendations. The prevalence ratios (PRs) and 95% confidence intervals (CIs) of MetS associated with the number of recommendations met were estimated using a binomial regression model. The adjusted PRs of MetS decreased with increasing number of recommendations met (p 0.001). Meeting all the five recommendations versus meeting none or only one was significantly associated with a 57% lower MetS prevalence (95% CI 0.35-0.73). Our results suggest that adherence to WCRF/AICR recommendations is a major determinant of MetS and may have a clinical impact.
- Published
- 2016
4. Adherence to WCRF/AICR cancer prevention recommendations and metabolic syndrome in breast cancer patients.
- Author
-
Bruno, Eleonora, Gargano, Giuliana, Villarini, Anna, Traina, Adele, Johansson, Harriet, Mano, Maria Piera, Santucci De Magistris, Maria, Simeoni, Milena, Consolaro, Elena, Mercandino, Angelica, Barbero, Maggiorino, Galasso, Rocco, Bassi, Maria Chiara, Zarcone, Maurizio, Zagallo, Emanuela, Venturelli, Elisabetta, Bellegotti, Manuela, Berrino, Franco, and Pasanisi, Patrizia
- Abstract
Metabolic syndrome (MetS), conventionally defined by the presence of at least three out of five dismetabolic traits (abdominal obesity, hypertension, low plasma HDL-cholesterol and high plasma glucose and triglycerides), has been associated with both breast cancer (BC) incidence and prognosis. We investigated the association between the prevalence of MetS and a score of adherence to the World Cancer Research Fund (WCRF) and American Institute for Cancer Research (AICR) recommendations for the prevention of cancer in a cross-sectional study of BC patients. The DIet and ANdrogen-5study (DIANA-5) for the prevention of BC recurrences recruited 2092 early stage BC survivors aged 35-70. At recruitment, all women completed a 24-hour food frequency and physical activity diary on their consumption and activity of the previous day. Using these diaries we created a score of adherence to five relevant WCRF/AICR recommendations. The prevalence ratios (PRs) and 95% confidence intervals (CIs) of MetS associated with the number of recommendations met were estimated using a binomial regression model. The adjusted PRs of MetS decreased with increasing number of recommendations met ( p < 0.001). Meeting all the five recommendations versus meeting none or only one was significantly associated with a 57% lower MetS prevalence (95% CI 0.35-0.73). Our results suggest that adherence to WCRF/AICR recommendations is a major determinant of MetS and may have a clinical impact. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.